| ADME | absorption, distribution, metabolism and excretion |
| AEA | anandamide, arachidonoylethanolamide |
| COX-2 | cyclooxygenase-2 |
| FAAH | fatty acid amide hydrolase |
| MC | mast cell |
| NAAA | N-acylethanolamine acid amidase |
| NAE | N-acylethanolamine |
| NAPE | N-acylphosphatidylethanolamines |
| NAPE–PLD | NAP hydrolysing phospholipase D |
| NAT | N-acyltransferase |
| NNT | Number Needed to Treat |
| OEA | oleoylethanolamide |
| PA | palmitic acid |
| PEA | palmitoylethanolamide, N-hexadecanoylethanolamide |
| PG | prostaglandin |
| PPAR-α | peroxisome proliferator-activated receptor-α |
| PtdEtn | phosphatidylethanolamine |
| TNF-α | tumour necrosis factor-α |
| TRPV1 | transient receptor potential vanilloid 1 |
| WOMAC | Western Ontario and McMaster Universities Osteoarthritis Index |